基于每日症状与局部激素使用监测的早期儿童特应性皮炎症状负担
研究纳入COPSAC2010队列700名儿童,通过每日日记记录AD症状天数和激素使用天数,评估生命前3年AD负担。AD患儿的中位症状天数为136天、激素天数为72天,疾病负担在出生后第2年最高。母亲AD和儿童过敏致敏与AD天数增多相关,母亲AD、丝聚蛋白突变和过敏致敏与激素天数增多相关。
要点
- AD患儿3年内约136天有症状、72天使用激素,第2年负担最重。
- 母亲AD和早期过敏致敏与AD症状天数增加相关。
- 母亲AD、丝聚蛋白突变和过敏致敏与激素使用天数增加相关。
核心结论
- 以AD天数和激素天数定量评估的儿童AD负担与母亲AD、丝聚蛋白突变和早期过敏致敏呈正相关,疾病负担在生命第2年最高。
研究设计与样本
- 基于COPSAC2010前瞻性队列,纳入700名儿童,通过每日日记记录AD和激素使用天数,分析18种可能的遗传、产前和产后环境暴露因素。
主要发现
- AD患儿生命前3年的中位(四分位距)症状天数为136天(61-294天),激素天数为72天(27-145天)。
- 多变量风险因素分析显示,母亲AD和儿童过敏致敏与AD天数增多相关。
- 母亲AD、丝聚蛋白突变和过敏致敏与激素天数增多相关。
局限性
- 对特应性疾病有个人兴趣的参与者可能更倾向于参加研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To our knowledge, disease burden of atopic dermatitis (AD) as number of days with symptoms and medical treatment has never been studied as measure of severity. OBJECTIVES: To investigate risk factors for AD burden in the first 3 years of life. METHODS: The Copenhagen Prospective Studies on Asthma in Childhood2010 included 700 children. AD burden was assessed by daily diary entries with information on AD and steroid days measuring 18 possible heritable, prenatal, and postnatal environmental exposures. RESULTS: The children with AD had a median (interquartile range) of 136 symptom days (61-294 days) and 72 steroid days (27-145 days) during the first 3 years of life, with the highest disease burden in the second year of life. The multivariable risk factor analysis showed that maternal AD and childhood allergic sensitization were associated with a higher number of AD days and maternal AD, filaggrin mutation, and allergic sensitization were associated with a higher number of steroid days. LIMITATIONS: Participants with a personal interest in atopic diseases could be more likely to participate. CONCLUSION: Children's burden of AD, assessed quantitatively as AD and steroid days, demonstrated positive associations with maternal AD, filaggrin mutation, and early-life allergic sensitization, with the highest disease burden in the second year of life.
引用
- Ruge IF, Thorsteinsdóttir S, Nørgaard S, et al. Symptom burden of atopic dermatitis in early childhood assessed from daily monitoring of symptoms and topical steroid use. J Am Acad Dermatol. 2020. PMID: 32950548. doi:10.1016/j.jaad.2020.09.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。